Biogen

Phone: +1 781-464-2000

Web: https://www.biogen.com

Formerly	Biogen Idec Inc. (2003–2015)
Type	Public company
Traded as	Nasdaq: BIIB NASDAQ-100 component S&P 500 component
Industry	Biotechnology
Founded	1978 (1978)
Founders	Kenneth Murray Phillip Allen Sharp Walter Gilbert Heinz Schaller Charles Weissmann
Headquarters	Cambridge, Massachusetts, U.S.
Key people	Stelios Papadopoulos (Chairman) Michel Vounatsos (CEO)
Products	Avonex, Fampyra, Plegridy, Tecfidera, Tysabri, Spinraza
Revenue	US$10.981 billion (2021)
Operating income	US$2.84 billion (2021)
Net income	US$1.727 billion (2021)
Total assets	US$23.877 billion (2021)
Total equity	US$10.96 billion (2021)
Number of employees	9,100 (2020)
Website	biogen.com

At Biogen, our mission is clear: we are pioneers in neuroscience. Since our founding in 1978 as one of the world’s first global biotechnology companies, Biogen has led innovative scientific research with the goal over the last decade to defeat devastating neurological diseases.

For detailed contact information visit location pages below.